Gilead Sciences Inc (GILD)
107.39
+0.65
(+0.61%)
USD |
NASDAQ |
May 23, 16:00
107.39
0.00 (0.00%)
After-Hours: 17:57
Gilead Sciences Market Cap: 133.59B for May 23, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen Inc | 146.11B |
| Johnson & Johnson | 367.95B |
| Eli Lilly and Co | 640.55B |
| Vertex Pharmaceuticals Inc | 111.97B |
| Moderna Inc | 10.16B |
Market Cap Related Metrics
| PE Ratio | 22.61 |
| PS Ratio | 4.712 |
| PEG Ratio | 0.0185 |
| Price to Book Value | 6.971 |
| Price to Free Cash Flow | 13.75 |
| Price | 107.39 |
| Earnings Yield | 4.42% |
| PEGY Ratio | 0.0185 |
| Operating PE Ratio | 12.59 |
| Normalized PE Ratio | 16.43 |